Beta Bionics (BBNX) Cash from Investing Activities Growth (1y) (2025 - 2026)
Beta Bionics (BBNX) Cash from Investing Activities Growth (1y) (2025 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.59 Bn | 150.93 Bn | 6.27 Bn | -4,224.26% |
| 2 | Stryker | 118.87 Bn | 115.99 Bn | 3.81 Bn | 95.53% |
| 3 | Medtronic | 104.25 Bn | 96.08 Bn | 5.76 Bn | 3.20% |
| 4 | Boston Scientific | 69.66 Bn | 68.44 Bn | 3.61 Bn | -18.20% |
| 5 | Edwards Lifesciences | 51.26 Bn | 47.59 Bn | 1.29 Bn | -208.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -187.82% |
| 7 | GE HealthCare Technologies | 28.80 Bn | 26.74 Bn | 1.98 Bn | -514.25% |
| 8 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | -397.90% |
| 9 | Steris | 20.31 Bn | 19.89 Bn | 697.10 Mn | -211.17% |
| 10 | Beta Bionics | 618.11 Mn | 587.80 Mn | 16.44 Mn | 112.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 112.19% |
| Dec 31, 2025 | 102.22% |
| Sep 30, 2025 | -37.76% |
| Jun 30, 2025 | 87.06% |
| Mar 31, 2025 | -2,443.30% |